The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients
| Autor: | S. Ünsal Delialioğlu, M. Dalyan Aras, S. Kibar |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
medicine.medical_specialty Cross-sectional study medicine.medical_treatment Antineoplastic Agents Breast Neoplasms Affect (psychology) Hypesthesia Upper Extremity 03 medical and health sciences 0302 clinical medicine Breast cancer Quality of life Musculoskeletal Pain Risk Factors medicine Humans Lymphedema Muscle Strength 030212 general & internal medicine Range of Motion Articular Muscle Skeletal Sensory deficit Radical mastectomy Aged business.industry Middle Aged medicine.disease Combined Modality Therapy Cross-Sectional Studies Oncology 030220 oncology & carcinogenesis Sensation Disorders Quality of Life Physical therapy Female Mastectomy Radical Range of motion business |
| Zdroj: | European Journal of Cancer Care. 26:e12433 |
| ISSN: | 0961-5423 |
| Popis: | This study aimed to determine the prevalence and identify the risk factors associated with upper extremity impairments (UEIs) in breast cancer patients and to investigate the degree to which these impairments and other characteristics influence quality of life (QoL). A total of 201 women over the age of 18 who underwent breast cancer treatment at least 6 months were included in this cross-sectional study. All of the patients were evaluated for the presence of lymphoedema and any UEIs. UEIs divided into five subgroups: pain, restriction of shoulder range of motion (ROM), numbness and heaviness, loss of strength, and sensory deficit. QoL of the patients was evaluated by SF-36. The prevalence of the upper extremity impairments was as follows: pain 31.8%, restriction of shoulder ROM 23.9%, numbness and heaviness 35.3%, loss of strength 8.5%, and sensory deficit 18.4%. Furthermore, lymphoedema was seen in 41.3% of patients. The multivariate model showed that lymphoedema is the only statistically significant risk factor that affects the development of UEIs (P = 0.001). However, it also revealed that lymphoedema (P = 0.001) and increased age negatively affect QoL, whereas prolongation of the follow-up period has a favourable impact (P = 0.016). Therefore, lymphoedema diminishes QoL via an increased number of UEIs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|